T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (Q94562592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

title

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Sailaja Gangadhara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

John P. Moore

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Cynthia A Derdeyn

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Eric Hunter

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

David Masopust

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Rama Rao Amara

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Bali Pulendran

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

17

Sudhir Pai Kasturi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

27

Purvesh Khatri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

29

Pamela A Kozlowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

14

Thomas J Ketas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

28

David Montefiori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

15

Traci Legere

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

7

Samantha L Burton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Caroline Petitdemange

9

object named as

Caroline Petitdemange

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

12

Clare F Quarnstrom

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

Pradeep Babu Jagadeesh Reddy

15 May 2020

16

object named as

Pradeep Babu Jagadeesh Reddy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

8

Celia C Labranche

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

21

Mark Tomai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

22

John Vasilakos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

2

Tysheena P Charles

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

11

Tiffany M Styles

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

author name string

Prabhu S Arunachalam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Venkata S Bollimpelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Madeleine K D Scott

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Florian Wimmers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Korey A Walter

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Anthony Tsai

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Bertrand Z Yeung

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Shakti Gupta

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

George M Shaw

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Chil-Yong Kang

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Shankar Subramaniam

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

publication date

11 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393800%20AND%20SRC:MED&resulttype=core&format=json

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Native-like Env trimers as a platform for HIV-1 vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

The T-cell response to HIV.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Vaccines that stimulate T cell immunity to HIV-1: the next step

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Memory CD8 T-cell compartment grows in size with immunological experience

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Impact of MHC class I diversity on immune control of immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

CD8(+) T cells in preventing HIV infection and disease

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Vaccine-induced CD8+ T cells control AIDS virus replication

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Sensing and alarm function of resident memory CD8⁺ T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Moving ahead an HIV vaccine: use both arms to beat HIV

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Measuring HIV neutralization in a luciferase reporter gene assay

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Simultaneous epitope and transcriptome measurement in single cells

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41591-020-0858-8

7 January 2021